Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • My Collection
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
Blood Plasma Exchange Networks | Helix | Envisioning
  1. Home
  2. Research
  3. Helix
  4. Blood Plasma Exchange Networks

Blood Plasma Exchange Networks

Regional clinics offering therapeutic plasma exchange for aging biomarkers.
BACK TO HELIX

Same technology in other hubs

Epoch
Epoch
Therapeutic Plasma Exchange

Blood renewal protocols that remove pro-aging factors and introduce youthful circulating factors.

Connections

Explore this signal in your context

Get a focused view of implications, timing, and action options for your organization.
Discuss this signal
VIEW INTERACTIVE VERSION
Applications
Applications
Systemic Milieu Reset Protocols

Plasmapheresis and plasma-mimetic therapies to rebalance pro- and anti-aging factors.

TRL
4/9
Impact
4/5
Investment
4/5
Applications
Applications
Partial Reprogramming Therapies

Transient expression of Yamanaka factors targeting aging phenotypes.

TRL
4/9
Impact
5/5
Investment
5/5
Applications
Applications
Immune System Rejuvenation Therapies

Interventions targeting thymic involution and clonal hematopoiesis in aging.

TRL
4/9
Impact
5/5
Investment
3/5
Applications
Applications
Swiss Longevity Clinic Models

Integrated programs combining biomarker labs, imaging, and concierge care.

TRL
7/9
Impact
3/5
Investment
3/5
Applications
Applications
Precision Longevity Interventions

Personalized stacks of therapeutics and lifestyle modifications.

TRL
7/9
Impact
4/5
Investment
4/5
Software
Software
In-Silico Longevity Drug Repurposing Engines

AI platforms identifying geroprotective properties in existing non-longevity drugs.

TRL
8/9
Impact
4/5
Investment
3/5

Therapeutic plasma exchange programs are networks of regional clinics that offer plasmapheresis (a procedure that removes, treats, and returns blood plasma) as a therapeutic intervention for aging, replacing aged plasma with albumin-enriched solutions based on research suggesting that young plasma contains factors that can rejuvenate aged tissues. Longevity clinics are rolling out plasmapheresis suites with standardized protocols, remote supervision capabilities, and bundled biomarker panels that track aging markers, making the therapy accessible beyond research centers and available to patients seeking anti-aging interventions. Companies and clinics are developing these services.

This innovation addresses research suggesting that factors in young blood can have rejuvenating effects, where plasma exchange could potentially transfer beneficial factors or remove harmful ones. By standardizing and scaling the procedure, these programs make it accessible to more people. However, the scientific basis and effectiveness remain areas of active research.

The technology is being explored for longevity applications, where plasma exchange could potentially have anti-aging effects. As research progresses, these programs could become more established. However, ensuring safety, demonstrating effectiveness, and managing costs remain challenges. The technology represents an interesting approach to anti-aging interventions, but requires continued research to establish efficacy and safety. Success could provide new options for healthy aging, but the scientific basis needs further validation and the approach must be carefully evaluated for safety and effectiveness.

TRL
6/9Demonstrated
Impact
4/5
Investment
4/5
Category
Applications

Newsletter

Follow us for weekly foresight in your inbox.

Browse the latest from Artificial Insights, our opinionated weekly briefing exploring the transition toward AGI.
Mar 8, 2026 · Issue 131
Mar 8, 2026 · Issue 131
Prompt it into existence
Feb 23, 2026 · Issue 130
Feb 23, 2026 · Issue 130
An Apocaloptimist
Feb 9, 2026 · Issue 129
Feb 9, 2026 · Issue 129
Agent in the Loop
View all issues